Mitotherapeutix

Developer of small molecules based drug using siRNA technology for various diseases

placeFarmington, Connecticut, United States calendar_todayFounded 2014 groups5 employees language mitotherapeutix.com

Innovation

2 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace slowing. Cited 72 times.

YearFilings
20201
20212
20222
20231

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital133%
Other / undisclosed267%
Coming soon